Clinical Trials List
2019-03-01 - 2023-12-31
Phase III
Terminated4
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 林泰祺 Division of Ophthalmology
- An-Fei Li Division of Ophthalmology
- 周昱百 Division of Ophthalmology
- De-Kuang Hwang Division of Ophthalmology
- 黃怡銘 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wei-Chi WU Division of Ophthalmology
- 陳彥伯 Division of Ophthalmology
- Yih-Shiou Hwang Division of Ophthalmology
- 周宏達 Division of Ophthalmology
- 陳冠任 Division of Ophthalmology
- 陳墩祿 Division of Ophthalmology
- 劉珍吟 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 莊智鈞 Division of Ophthalmology
- 吳艾玲 Division of Ophthalmology
- 胡毓真 Division of Ophthalmology
- 李昆憲 Division of Ophthalmology
- 陳延誌 Division of Ophthalmology
- San-Ni Chen Division of Ophthalmology
- 鄭捷尹 Division of Ophthalmology
- 謝明潔 Division of Ophthalmology
- 吳建昇 Division of Ophthalmology
- 陳鶴齡 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 葉伯廷 Division of Ophthalmology
- CHUNG-MAY YANG Division of Ophthalmology
- 謝易庭 Division of Ophthalmology
- Ta-Ching Chen Division of Ophthalmology
- TSO-TING LAI Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
28 participants
-
Global
640 participants
